EXICURE, INC. Debt Securities Held To Maturity Fair Value Noncurrent
EXICURE, INC. (XCUR) had Debt Securities Held To Maturity Fair Value Noncurrent of $2.00 million as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesHeldToMaturityFairValueNoncurrent · last filed 2023-08-11
- 2023-06-30: Debt Securities Held To Maturity Fair Value Noncurrent $2.00M.
- 2022-12-31: Debt Securities Held To Maturity Fair Value Noncurrent $0.00.
| Period end | Debt Securities Held To Maturity Fair Value Noncurrent |
|---|---|
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |